. The white blood cell count was 20-3 x 109/l (95% neutrophils) but no organisms were identified in numerous sputum samples. The results of the following investigations were normal or negative: sputum cytology for malignant cells, viral antibodies, cold aggluti-
nins, antibodies to Legionella pneumophila and Mycoplasma pneumoniae, and skinprick test responses and precipitins to A fumigatus. Treatment was changed to penicillin, metronidazole, and flucloxacillin. The prednisolone was increased to 40 mg daily.
Fibreoptic bronchoscopy showed no endobronchial lesion and washings and brushings yielded no abnormalities. Biopsy showed severely inflamed and partly necrotic bronchus, neutrophil infiltration of alveolar walls, and a separate fragment composed of fungal hyphae, tentatively identified as Aspergillus. Itraconazole was added to her treatment. The patient was unfit for surgery and despite intensive physiotherapy deteriorated and died eight days after admission. The total duration of her terminal illness was 35 days.
At postmortem examination a 3 cm diameter cavity in the right upper lobe was seen to be surrounded by extensive consolidation. The cavity was partly lined by plaques of a white mould (fig 2) , culture of which yielded a moderate growth of A niger and a heavy growth of Candida albicans. Microscopy of the plaques showed a dense tangle of aspergillus hyphae and candida spores. The cavity lacked an epithelial lining and fibrous capsule. Its wall was formed of a The cavities that develop in chronic necrotising aspergillus pneumonia frequently contain ball like collections resembling aspergillomas.2 These collections often comprise heavily infected necrotic lung tissue and the term sequestrum is preferable to aspergilloma.' In this and other cases, a pure colony of fungus is found in the cavity with invasion of the adjacent lung. This primary local invasion distinguishes chronic necrotising aspergillus pneumonia from aspergilloma. The latter is a saprophytic colonisation of a preformed cavity, whereas in the former the cavity is newly formed and a consequence of the infection.
The role of the associated candida infection in our patient is uncertain. Virus infections, such as influenza, may predispose to invasive aspergillosis,6 but in our patient there was no evidence of prior virus infection.
Our case emphasises that chronic necrotising aspergillus pneumonia may occur in patients who do not have severe immunosuppression, though like many others a quarter of one series2-she was taking long term oral corticosteroids.
This treatment in conjunction with recurrent courses of systemic antibiotics may predispose patients with chronic airflow limitation to this indolent form of invasive aspergillosis. The diagnosis therefore needs to be considered in patients with chronic airflow limitation who develop cavitating pneumonia. Unfortunately, the diagnosis may be difficult to establish as tests for aspergillus precipitins may give negative results,2 particularly in patients taking oral corticosteroids, and the relevance of fungi in sputum is difficult to assess in patients having long term antibiotics.
Chronic necrotising aspergillus pneumonia carries a high mortality rate3 and our therapeutic measures were unsuccessful. Early treatment with systemic amphotericin with or without flucytosine may be successful,7 but greater experience with these agents is needed in this disorder.
We are indebted to Dr R Hay for his invaluable advice. 
